Wednesday, May 28, 2014 12:03:02 AM
This claim directly contradicts what was then and is still currently posted on the MJFF web site.
It's clear someone believes they have a better understanding of LymPro demand than the researchers and physicians Gerald and his advisors are in communication with, suggesting the corporate advisors are misguided in their efforts to bring the LymPro test to market. Time will tell, but the demand we see for LymPro once it is available will prove who is right and who is wrong in their beliefs.
It's also clear someone believes they have a better understanding of PD than the MJFF researchers themselves. Someone with this level of understanding should probably be involved in the MJFF research efforts, no?
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM